HeartPub Date : 2024-08-14DOI: 10.1136/heartjnl-2024-324331
Paul Geenty, Liza Thomas
{"title":"Plot thickens: the progression of left ventricular 'hypertrophy' in Fabry disease.","authors":"Paul Geenty, Liza Thomas","doi":"10.1136/heartjnl-2024-324331","DOIUrl":"10.1136/heartjnl-2024-324331","url":null,"abstract":"","PeriodicalId":12835,"journal":{"name":"Heart","volume":null,"pages":null},"PeriodicalIF":5.1,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141751512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HeartPub Date : 2024-08-14DOI: 10.1136/heartjnl-2023-323822
Chun-Ka Wong, Yuk Ming Lau, Hin Wai Lui, Wai Fung Chan, Wing Chun San, Mi Zhou, Yangyang Cheng, Duo Huang, Wing Hon Lai, Yee Man Lau, Chung Wah Siu
{"title":"Automatic detection of cardiac conditions from photos of electrocardiogram captured by smartphones.","authors":"Chun-Ka Wong, Yuk Ming Lau, Hin Wai Lui, Wai Fung Chan, Wing Chun San, Mi Zhou, Yangyang Cheng, Duo Huang, Wing Hon Lai, Yee Man Lau, Chung Wah Siu","doi":"10.1136/heartjnl-2023-323822","DOIUrl":"10.1136/heartjnl-2023-323822","url":null,"abstract":"<p><strong>Background: </strong>Researchers have developed machine learning-based ECG diagnostic algorithms that match or even surpass cardiologist level of performance. However, most of them cannot be used in real-world, as older generation ECG machines do not permit installation of new algorithms.</p><p><strong>Objective: </strong>To develop a smartphone application that automatically extract ECG waveforms from photos and to convert them to voltage-time series for downstream analysis by a variety of diagnostic algorithms built by researchers.</p><p><strong>Methods: </strong>A novel approach of using objective detection and image segmentation models to automatically extract ECG waveforms from photos taken by clinicians was devised. Modular machine learning models were developed to sequentially perform waveform identification, gridline removal, and scale calibration. The extracted data were then analysed using a machine learning-based cardiac rhythm classifier.</p><p><strong>Results: </strong>Waveforms from 40 516 scanned and 444 photographed ECGs were automatically extracted. 12 828 of 13 258 (96.8%) scanned and 5399 of 5743 (94.0%) photographed waveforms were correctly cropped and labelled. 11 604 of 12 735 (91.1%) scanned and 5062 of 5752 (88.0%) photographed waveforms achieved successful voltage-time signal extraction after automatic gridline and background noise removal. In a proof-of-concept demonstration, an atrial fibrillation diagnostic algorithm achieved 91.3% sensitivity, 94.2% specificity, 95.6% positive predictive value, 88.6% negative predictive value and 93.4% F1 score, using photos of ECGs as input.</p><p><strong>Conclusion: </strong>Object detection and image segmentation models allow automatic extraction of ECG signals from photos for downstream diagnostics. This novel pipeline circumvents the need for costly ECG hardware upgrades, thereby paving the way for large-scale implementation of machine learning-based diagnostic algorithms.</p>","PeriodicalId":12835,"journal":{"name":"Heart","volume":null,"pages":null},"PeriodicalIF":5.1,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141070820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HeartPub Date : 2024-08-14DOI: 10.1136/heartjnl-2024-324589
Jenny Doust
{"title":"Improving how we determine who should take blood pressure and lipid-lowering medications.","authors":"Jenny Doust","doi":"10.1136/heartjnl-2024-324589","DOIUrl":"10.1136/heartjnl-2024-324589","url":null,"abstract":"","PeriodicalId":12835,"journal":{"name":"Heart","volume":null,"pages":null},"PeriodicalIF":5.1,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141751511","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HeartPub Date : 2024-08-14DOI: 10.1136/heartjnl-2024-324299
Rohan Khera
{"title":"AI-enabled diagnosis from an electrocardiogram image: the next frontier of innovation in a century-old technology.","authors":"Rohan Khera","doi":"10.1136/heartjnl-2024-324299","DOIUrl":"10.1136/heartjnl-2024-324299","url":null,"abstract":"","PeriodicalId":12835,"journal":{"name":"Heart","volume":null,"pages":null},"PeriodicalIF":5.1,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11328242/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141758271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HeartPub Date : 2024-08-14DOI: 10.1136/heartjnl-2022-322001
Cara Barnes, Harish Sharma, James Gamble, Sam Dawkins
{"title":"Management of secondary mitral regurgitation: from drugs to devices.","authors":"Cara Barnes, Harish Sharma, James Gamble, Sam Dawkins","doi":"10.1136/heartjnl-2022-322001","DOIUrl":"10.1136/heartjnl-2022-322001","url":null,"abstract":"<p><p>Severe secondary mitral regurgitation carries a poor prognosis with one in five patients dying within 12 months of diagnosis. Fortunately, there are now a number of safe and effective therapies available to improve outcomes. Here, we summarise the most up-to-date treatments. Optimal guideline-directed medical therapy is the mainstay therapy and has been shown to reduce the severity of mitral regurgitation in 40-45% of patients. Rapid medication titration protocols reduce heart failure hospitalisation and facilitate earlier referral for device therapy. The pursuit of sinus rhythm in patients with atrial fibrillation has been shown to significantly reduce mitral regurgitation severity, as has the use of cardiac resynchronisation devices in patients who meet guideline-directed criteria. Finally, we highlight the key role of mitral valve intervention, particularly transcatheter edge-to-edge repair (TEER) for management of moderate-severe mitral regurgitation in carefully selected patients with poor left ventricular systolic function, with a number needed to treat of 3.1 to reduce heart failure hospitalisation and 5.9 to reduce all-cause death. To slow the rapid accumulation of morbidity and mortality, we advocate a proactive approach with accelerated medical optimisation, followed by management of atrial fibrillation and cardiac resynchronisation therapy if indicated, then, rapid referral to the Heart Team for consideration of mitral valve intervention in patients with ongoing symptoms and at least moderate-severe mitral regurgitation. Mitral TEER has been shown to be 'reasonably cost-effective' (but not cost-saving) in the UK in selected patients, although TEER remains underused with only 6.5 procedures per million population (pmp) compared with Germany (77 pmp), Switzerland (44 pmp) and the USA (32 pmp).</p>","PeriodicalId":12835,"journal":{"name":"Heart","volume":null,"pages":null},"PeriodicalIF":5.1,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11347202/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10052174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HeartPub Date : 2024-08-01DOI: 10.1136/heartjnl-2024-324219
Alexander P Hoffmann, Elliot J Stein, Neal A Chatterjee
{"title":"A diagnostically challenging case of wide complex tachycardia","authors":"Alexander P Hoffmann, Elliot J Stein, Neal A Chatterjee","doi":"10.1136/heartjnl-2024-324219","DOIUrl":"https://doi.org/10.1136/heartjnl-2024-324219","url":null,"abstract":"A woman in her 60s with non-obstructive coronary artery disease, aortic valve replacement and aortic arch repair, chronic diastolic heart failure and paroxysmal atrial fibrillation (AF) and flutter (AFL), presented with 3 days of sustained palpitations that felt similar to prior episodes of AF/AFL. She was euvolemic, haemodynamically stable, with a regular rhythm. Home medications included apixaban, carvedilol and flecainide. Presenting ECG (figure 1A) was compared with baseline ECG (figure 1B) and ECG from a recent admission for AF with rate-related aberrancy (figure 1C). There was no atrioventricular dissociation or fusion/capture beats. High-sensitivity troponin I was undetectable. Serum creatinine had fluctuated recently between 1.3 and 2.0 mg/dL from a baseline of 1.0 mg/dL (estimated glomerular filtration rate approximately 25–45 from a baseline of >60 mL/min/1.73 m2). Electrolytes …","PeriodicalId":12835,"journal":{"name":"Heart","volume":null,"pages":null},"PeriodicalIF":5.7,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141573354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HeartPub Date : 2024-07-25DOI: 10.1136/heartjnl-2024-323913
Love Cyon, Erik Kadesjö, Gustaf Edgren, Andreas Roos
{"title":"Long-term prognosis of low high-sensitivity cardiac troponin T in the emergency department compared with the general population.","authors":"Love Cyon, Erik Kadesjö, Gustaf Edgren, Andreas Roos","doi":"10.1136/heartjnl-2024-323913","DOIUrl":"10.1136/heartjnl-2024-323913","url":null,"abstract":"<p><strong>Background: </strong>Long-term prognosis associated with low-high-sensitivity cardiac troponin T (hs-cTnT) concentrations in patients with chest pain is unknown. We investigated these prognostic implications compared with the general population.</p><p><strong>Methods: </strong>All first visits to seven emergency departments (ED)s in Sweden were included from 9 December 2010 to 31 August, 2017 by patients presenting with chest pain and at least one hs-cTnT measured. Patients with myocardial injury (any hs-cTnT >14 ng/L), including patients with myocardial infarction (MI) were excluded. Standardised mortality ratios (SMRs) and standardised incidence ratios (SIRs) were calculated as the ratio of the number of observed to expected events. The expected number was computed by multiplying the 1-year calendar period-specific, age-specific and sex-specific follow-up time in the cohort with the corresponding incidence in the general population. HRs were calculated for all-cause mortality and major adverse cardiovascular events (MACE), defined as acute MI, heart failure hospitalisation, cerebrovascular stroke or cardiovascular death, between patients with undetectable (<5 ng/L) and low (5-14 ng/L) hs-cTnT.</p><p><strong>Results: </strong>A total of 1 11 916 patients were included, of whom 69 090 (62%) and 42 826 (38%) had peak hs-cTnT concentrations of <5 and 5-14 ng/L. Patients with undetectable peak hs-cTnT had a lower mortality risk compared with the general Swedish population (SMR 0.83, 95% CI 0.79 to 0.87), with lower risks observed in all patients ≥65 years of age, but a slightly higher risk of being diagnosed with a future MI (SIR 1.39, 95% CI 1.32 to 1.47). The adjusted risk of a first MACE associated with low versus undetectable peak hs-cTnT was 1.6-fold (HR 1.61, 95% CI 1.53 to 1.70).</p><p><strong>Conclusion: </strong>Patients with chest pain and undetectable hs-cTnT have an overall lower risk of death compared with the general population, with risks being highly age dependent. Detectable hs-cTnT concentrations are still associated with increased long-term cardiovascular risks.</p>","PeriodicalId":12835,"journal":{"name":"Heart","volume":null,"pages":null},"PeriodicalIF":5.1,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11287531/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141288015","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HeartPub Date : 2024-07-25DOI: 10.1136/heartjnl-2024-324143
Nick Curzen
{"title":"Angiogram-derived physiology: will it change the game or miss the boat?","authors":"Nick Curzen","doi":"10.1136/heartjnl-2024-324143","DOIUrl":"10.1136/heartjnl-2024-324143","url":null,"abstract":"","PeriodicalId":12835,"journal":{"name":"Heart","volume":null,"pages":null},"PeriodicalIF":5.1,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141491715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HeartPub Date : 2024-07-25DOI: 10.1136/heartjnl-2024-324039
Mina Ghobrial, Hazel Haley, Rebecca Gosling, Daniel James Taylor, James Richardson, Kenneth Morgan, David Barmby, Javaid Iqbal, Arvindra Krishnamurthy, Rajender Singh, Dwayne Conway, Ian Hall, Zulfiquar Adam, Nigel Wheeldon, Ever D Grech, Robert F Storey, Alexander Rothman, Gillian Payne, Muhammad Naeem Tahir, Simon Smith, Justin Cooke, Steven Hunter, Neil Cartwright, Syed Sadeque, Norman Paul Briffa, Abdallah Al-Mohammad, Laurence O'Toole, Dominic Rogers, Patricia V Lawford, David R Hose, Julian Gunn, Paul D Morris
{"title":"Modelled impact of virtual fractional flow reserve in patients undergoing coronary angiography (VIRTU-4).","authors":"Mina Ghobrial, Hazel Haley, Rebecca Gosling, Daniel James Taylor, James Richardson, Kenneth Morgan, David Barmby, Javaid Iqbal, Arvindra Krishnamurthy, Rajender Singh, Dwayne Conway, Ian Hall, Zulfiquar Adam, Nigel Wheeldon, Ever D Grech, Robert F Storey, Alexander Rothman, Gillian Payne, Muhammad Naeem Tahir, Simon Smith, Justin Cooke, Steven Hunter, Neil Cartwright, Syed Sadeque, Norman Paul Briffa, Abdallah Al-Mohammad, Laurence O'Toole, Dominic Rogers, Patricia V Lawford, David R Hose, Julian Gunn, Paul D Morris","doi":"10.1136/heartjnl-2024-324039","DOIUrl":"10.1136/heartjnl-2024-324039","url":null,"abstract":"<p><strong>Background: </strong>The practical application of 'virtual' (computed) fractional flow reserve (vFFR) based on invasive coronary angiogram (ICA) images is unknown. The objective of this cohort study was to investigate the potential of vFFR to guide the management of unselected patients undergoing ICA. The hypothesis was that it changes management in >10% of cases.</p><p><strong>Methods: </strong>vFFR was computed using the Sheffield VIRTUheart system, at five hospitals in the North of England, on 'all-comers' undergoing ICA for non-ST-elevation myocardial infarction acute coronary syndrome (ACS) and chronic coronary syndrome (CCS). The cardiologists' management plan (optimal medical therapy, percutaneous coronary intervention (PCI), coronary artery bypass surgery or 'more information required') and confidence level were recorded after ICA, and again after vFFR disclosure.</p><p><strong>Results: </strong>517 patients were screened; 320 were recruited: 208 with ACS and 112 with CCS. The median vFFR was 0.82 (0.70-0.91). vFFR disclosure did not change the mean number of significantly stenosed vessels per patient (1.16 (±0.96) visually and 1.18 (±0.92) with vFFR (p=0.79)). A change in intended management following vFFR disclosure occurred in 22% of all patients; in the ACS cohort, there was a 62% increase in the number planned for medical management, and in the CCS cohort, there was a 31% increase in the number planned for PCI. In all patients, vFFR disclosure increased physician confidence from 8 of 10 (7.33-9) to 9 of 10 (8-10) (p<0.001).</p><p><strong>Conclusion: </strong>The addition of vFFR to ICA changed intended management strategy in 22% of patients, provided a detailed and specific 'all-in-one' anatomical and physiological assessment of coronary artery disease, and was accompanied by augmentation of the operator's confidence in the treatment strategy.</p>","PeriodicalId":12835,"journal":{"name":"Heart","volume":null,"pages":null},"PeriodicalIF":5.1,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11287621/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140956427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}